Target intelligence / Profile preview

Intestinal enterocyte villus mannose residues

Molecular classification
Carbohydrate, Glycan, Post-translational modification
01

Overview

Intestinal enterocyte villus mannose residues are high-mannose glycans located on the apical surface of intestinal epithelial cells. These carbohydrate structures serve as critical attachment points for various pathogens, most notably Adherent-Invasive Escherichia coli (AIEC) and Uropathogenic Escherichia coli (UPEC), which utilize the FimH adhesin to bind to these residues [1, 2]. This interaction facilitates bacterial colonization, invasion of the gut wall, and the subsequent inflammatory cascade characteristic of diseases like Crohn's disease [3, 10]. In pharmacological contexts, these residues are targeted by anti-adhesive agents such as Sibofimloc (EB8018) or D-mannose, which act as competitive inhibitors to block bacterial binding [5, 11]. By preventing the attachment of pro-inflammatory bacteria to the intestinal lining, these therapies aim to reduce mucosal inflammation and maintain gut homeostasis without disrupting the commensal microbiome [6, 8].

Other names
High-mannose glycansMannosylated glycoproteinsEnterocyte surface mannoseIntestinal epithelial mannose residuesHigh-mannose oligosaccharides
02

Mechanism of action

Competitive inhibition of bacterial adhesin (FimH) binding to host cell surface mannose residues, preventing bacterial colonization and invasion.

03

Biological functions

Cell-cell recognitionPathogen adhesionProtein folding and traffickingMucosal innate defense
04

Disease associations

Crohn's diseaseInfectionInflammatory bowel diseaseUrinary tract infection
05

Safety considerations

Minimal systemic absorptionPotential interference with host glycan-mediated signalingGut-restricted therapeutic effects
06

Interacting drugs

Sibofimloc (EB8018/TAK-018)

2 more in the full profile.

07

Biomarkers

FimH-expressing bacteriaSerum mannose levelsCEACAM6 expression

Beyond the preview

Go deeper on Intestinal enterocyte villus mannose residues.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal enterocyte villus mannose residues.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call